Insulet Corporation

Healthcare · Medical Devices

140.60$ -0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Insulet Corporation (PODD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 802 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PODD
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	433	510	442	489	544	598	569	649	706	784	762	802	3,054
Cost of Revenue	139	149	135	158	167	167	160	197	196	215	233	239	883
Gross Profit	293	361	307	331	377	431	409	452	510	569	529	563	2,170
Research & Development	58	42	50	54	55	61	60	73	77	91	90	88	346
Selling, General & Administrative	168	191	190	222	206	237	241	258	315	331	317	345	1,309
Total Operating Expenses	239	255	250	276	289	322	320	331	392	422	407	433	1,655
Operating Income	55	106	57	55	88	109	89	121	118	146	122	130	516
Interest Expense	10	6.7	11	11	12	8.7	9.2	20	16	20	15	14	63
Pre-Tax Income	54	108	55	51	83	111	48	28	123	140	113	119	495
Income Tax Expense	1.8	4.5	3.4	-138	5.4	11	13	5.9	35	39	22	24	119
Net Income	52	103	52	189	78	101	35	23	88	102	91	95	375
EBITDA	83	133	84	81	117	142	79	70	160	190	154	132	637

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings